Allievex
OverviewSuggest Edit
Allievex is a company building a portfolio of therapeutics for the treatment of rare pediatric neurodegenerative diseases. It develops tralesinidase alfa for the treatment of children with Sanfilippo syndrome Type B, also known as Mucopolysaccharidosis IIIB (MPS IIIB).
| Type | Private | |
| Founded | 2019 | |
| HQ | Marblehead, MA, US | Map |
| Website | allievex.com |
Locations
Latest Updates
| Employees (est.) (Feb 2021) | 8 | (-11%) |
| Cybersecurity rating | A | More |
Key People/Management at Allievex
Thomas P. Mathers
President and Chief Executive Officer
Eric H. Zanelli
Head of Research
Steve Maricich
Chief Medical Officer
Joe Kovalchin
Executive Director of Research
Sean Deller
Senior Director of Technical Operations
Allievex Financials and Metrics
Summary Metrics
Founding Date | 2019 |
Allievex Cybersecurity Score
Allievex Online and Social Media Presence
23 Twitter followers
Allievex has 23 Twitter Followers. The number of followers has increased 0.9% month over month and increased 13.7% quarter over quarter
Allievex's Trends
Allievex Frequently Asked Questions
When was Allievex founded?
Allievex was founded in 2019.
Who are Allievex key executives?
Allievex's key executives are Thomas P. Mathers, Eric H. Zanelli and Steve Maricich.
How many employees does Allievex have?
Allievex has 8 employees.
Who are Allievex competitors?
Competitors of Allievex include Kymera Therapeutics, MedDay and Bicycle Therapeutics.
Where are Allievex offices?
Allievex has an office in Marblehead.
How many offices does Allievex have?
Allievex has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies